Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adeline Duc"'
Autor:
Philippe A. Cassier, Marie Paturel, Armelle Dufresne, Jean-Yves Blay, Anne-Valérie Decouvelaere, Laurent Alberti, Heloise Philippon, Adeline Duc
Publikováno v:
Cancer Science
Desmoid tumor is a rare connective tissue tumor with locoregional aggressiveness but unpredictable behavior. The miRNA profile was ascertained for 26 patients included in the Desminib phase II trial and an independent validation cohort of 15 patients
Autor:
Adeline Duc, Anthony Besse, Daniel Pissaloux, Angélique Gougelet, Aurélie Dutour, Jean-Yves Blay, Laurent Alberti, Jennifer Perez
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2011, 129 (3), pp.680-690. ⟨10.1002/ijc.25715⟩
International Journal of Cancer, 2011, 129 (3), pp.680-690. ⟨10.1002/ijc.25715⟩
International Journal of Cancer, Wiley, 2011, 129 (3), pp.680-690. ⟨10.1002/ijc.25715⟩
International Journal of Cancer, 2011, 129 (3), pp.680-690. ⟨10.1002/ijc.25715⟩
Micro-RNAs (miRNA) are currently used as cancer biomarkers for hematological cancers and solid tumors. Osteosarcoma is the first primary malignant bone tumor, characterized by a complex genetic and resistance to conventional treatments. For this latt
Autor:
J-Y. Blay, Rastkha M, Thomas Bachelot, Adeline Duc, Isabelle Ray-Coquard, Christine Ménétrier-Caux
Publikováno v:
British Journal of Cancer
Prediction of survival for patients with metastatic breast cancer is often inaccurate and may be helped by new biological parameters. Tumour growth being angiogenesis-dependent, it has been hypothesised that the assessment of angiogenic factor produc
Autor:
L. Gebuhrer, Sylvie Negrier, C. Bain, Christine Lasset, Marie Favrot, T Philip, Adeline Duc, I. Puisieux, V. Bonadona, Yacine Merrouche, J.-Y. Blay, F. Lanier
Publikováno v:
British Journal of Cancer
HLA phenotypes were characterized for 79 patients with metastatic renal cell carcinoma treated with interleukin 2 (IL-2). HLA-A32 was associated with a clinical response (P = 0.025). The frequency of HLA-A3 and/or A32 was higher among responders than
Autor:
Laurent Alberti, Jean-Yves Blay, Anne-Valérie Decouvelaere, Anthony Besse, Dominique Ranchère-Vince, Angélique Gougelet, Adeline Duc, Daniel Pissaloux, Jennifer Perez
Publikováno v:
Sarcoma, Vol 2011 (2011)
Sarcoma
Sarcoma, Hindawi Publishing Corporation, 2011, 2011, pp.460650. ⟨10.1155/2011/460650⟩
BASE-Bielefeld Academic Search Engine
Sarcoma
Sarcoma, Hindawi Publishing Corporation, 2011, 2011, pp.460650. ⟨10.1155/2011/460650⟩
BASE-Bielefeld Academic Search Engine
International audience; Sarcomas are divided into a group with specific alterations and a second presenting a complex karyotype, sometimes difficult to diagnose or with few therapeutic options available. We assessed if miRNA profiling by TaqMan low d